| |
|
|
|
GenMark Diagnostics Inc.  
|
|
6.76 -0.14 (-0.02%) |
06-14 16:00 |
|
Open: |
6.92 |
Pre close: |
6.9 |
Target:
|
8.37 
|
|
High: |
6.99 |
Low: |
6.74 |
Resistance:
|
7.17
7.56
|
|
Volume: |
160,229 |
Market Cap: |
386M |
Support:
|
6.54
5.44
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
6.89
 |
MACD |
MACD(12,26):
|
-0.08 |
|
MA(20): |
6.80 |
Signal(12,26,9): |
-0.11 |
|
MA(100): |
6.99 |
Stochastic Oscillator |
%K(14,3):
|
62.29 |
|
MA(250): |
6.56 |
%D(3): |
69.61 |
|
Average Volume(K) |
3-Month: |
25137
|
52-Week |
High:
|
8.81 |
|
10-Days: |
21976 |
Low: |
3.58 |
|
RSI |
RSI(14):
|
43.43 |
Change(%): |
-7.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.920 |
Return on Equity (ttm) |
-117.6 |
Shares Out. (M) |
57.03 |
|
EPS Est. Current Year |
-1.070 |
Return on Assets (ttm) |
-49.2 |
Shares Float (M) |
53.06 |
|
EPS Est. Next Year |
-0.690 |
PEG Ratio |
0.21 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.140 |
Qtrly Rev. Growth |
4.3 |
% Held by Institutions |
0.00 |
|
Forward EPS |
-0.630 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
15.890 |
EBITDA (p.s.) |
0.000 |
P/E |
-7.35 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.43 |
|
Profit Margin |
-71.77 |
Operating Cash Flow
(M) |
-34.64 |
P/S |
301189696.00 |
|
Operating Margin |
-66.84 |
Levered Free Cash Flow
(M) |
-17.36 |
P/CF |
-11.13 |
|
|
|
|
|
|
